Free Trial
→ $30 stock to buy before Starlink goes public (WATCH NOW!) (From Paradigm Press) (Ad)tc pixel Free CRON Stock Alerts

Cronos Group (CRON) Competitors

Cronos Group logo
C$3.60 -0.03 (-0.83%)
As of 04:00 PM Eastern
Compare

CRON vs. APHA, PBH, BHC, SLS, and AUP

Should you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aphria (APHA), Premium Brands (PBH), Bausch Health Companies (BHC), Solaris Resources (SLS), and Aurinia Pharmaceuticals (AUP). These companies are all part of the "pharmaceutical products" industry.

How does Cronos Group compare to Aphria?

Cronos Group (TSE:CRON) and Aphria (TSE:APHA) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Cronos Group presently has a consensus target price of C$4.38, suggesting a potential upside of 21.53%. Given Cronos Group's stronger consensus rating and higher probable upside, equities analysts clearly believe Cronos Group is more favorable than Aphria.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Cronos Group has higher earnings, but lower revenue than Aphria. Cronos Group is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$146.59M9.24-C$32.78M-C$0.02N/A
AphriaC$611.06M0.00-C$637.39M-C$2.01N/A

Aphria has a net margin of 0.00% compared to Cronos Group's net margin of -6.37%. Aphria's return on equity of 0.00% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-6.37% -0.87% -3.73%
Aphria N/A N/A N/A

In the previous week, Cronos Group had 1 more articles in the media than Aphria. MarketBeat recorded 1 mentions for Cronos Group and 0 mentions for Aphria. Cronos Group's average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company Overall Sentiment
Cronos Group Neutral
Aphria Neutral

4.4% of Cronos Group shares are held by institutional investors. 46.4% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Cronos Group beats Aphria on 8 of the 13 factors compared between the two stocks.

How does Cronos Group compare to Premium Brands?

Cronos Group (TSE:CRON) and Premium Brands (TSE:PBH) are both pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Cronos Group presently has a consensus target price of C$4.38, suggesting a potential upside of 21.53%. Premium Brands has a consensus target price of C$116.36, suggesting a potential upside of 40.35%. Given Premium Brands' higher possible upside, analysts plainly believe Premium Brands is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Premium Brands
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00

Cronos Group has a beta of 1.036621, suggesting that its share price is 4% more volatile than the S&P 500. Comparatively, Premium Brands has a beta of 0.860077, suggesting that its share price is 14% less volatile than the S&P 500.

Premium Brands has a net margin of 0.54% compared to Cronos Group's net margin of -6.37%. Premium Brands' return on equity of 2.38% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-6.37% -0.87% -3.73%
Premium Brands 0.54%2.38%3.61%

4.4% of Cronos Group shares are held by institutional investors. Comparatively, 33.0% of Premium Brands shares are held by institutional investors. 46.4% of Cronos Group shares are held by company insiders. Comparatively, 2.0% of Premium Brands shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Premium Brands had 5 more articles in the media than Cronos Group. MarketBeat recorded 6 mentions for Premium Brands and 1 mentions for Cronos Group. Premium Brands' average media sentiment score of 0.39 beat Cronos Group's score of 0.00 indicating that Premium Brands is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cronos Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Premium Brands
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Premium Brands has higher revenue and earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$146.59M9.24-C$32.78M-C$0.02N/A
Premium BrandsC$7.48B0.58C$99.56MC$0.9092.12

Summary

Premium Brands beats Cronos Group on 13 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Cronos Group (TSE:CRON) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

Cronos Group has a consensus target price of C$4.38, indicating a potential upside of 21.53%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts clearly believe Cronos Group is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Bausch Health Companies has a beta of 0.588188, indicating that its stock price is 41% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.036621, indicating that its stock price is 4% more volatile than the S&P 500.

Cronos Group has a net margin of -6.37% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch Health Companies-13.54% 120.43% 4.16%
Cronos Group -6.37%-0.87%-3.73%

13.5% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 4.4% of Cronos Group shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by insiders. Comparatively, 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Bausch Health Companies had 3 more articles in the media than Cronos Group. MarketBeat recorded 4 mentions for Bausch Health Companies and 1 mentions for Cronos Group. Bausch Health Companies' average media sentiment score of 0.22 beat Cronos Group's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch Health Companies
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cronos Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Cronos Group has lower revenue, but higher earnings than Bausch Health Companies. Cronos Group is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/A
Cronos GroupC$146.59M9.24-C$32.78M-C$0.02N/A

Summary

Cronos Group beats Bausch Health Companies on 9 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Solaris Resources?

Solaris Resources (TSE:SLS) and Cronos Group (TSE:CRON) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

Cronos Group has higher revenue and earnings than Solaris Resources. Cronos Group is trading at a lower price-to-earnings ratio than Solaris Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solaris ResourcesN/AN/A-C$46.49M-C$0.26N/A
Cronos GroupC$146.59M9.24-C$32.78M-C$0.02N/A

Solaris Resources has a beta of 1.845161, indicating that its stock price is 85% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.036621, indicating that its stock price is 4% more volatile than the S&P 500.

Solaris Resources currently has a consensus target price of C$19.50, indicating a potential upside of 47.17%. Cronos Group has a consensus target price of C$4.38, indicating a potential upside of 21.53%. Given Solaris Resources' higher probable upside, equities analysts clearly believe Solaris Resources is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solaris Resources
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Solaris Resources has a net margin of 0.00% compared to Cronos Group's net margin of -6.37%. Solaris Resources' return on equity of 96.23% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Solaris ResourcesN/A 96.23% -51.67%
Cronos Group -6.37%-0.87%-3.73%

In the previous week, Solaris Resources and Solaris Resources both had 1 articles in the media. Solaris Resources' average media sentiment score of 0.48 beat Cronos Group's score of 0.00 indicating that Solaris Resources is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solaris Resources
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cronos Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

16.1% of Solaris Resources shares are owned by institutional investors. Comparatively, 4.4% of Cronos Group shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by insiders. Comparatively, 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Solaris Resources beats Cronos Group on 7 of the 13 factors compared between the two stocks.

How does Cronos Group compare to Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals (TSE:AUP) and Cronos Group (TSE:CRON) are both pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

Cronos Group has higher revenue and earnings than Aurinia Pharmaceuticals. Cronos Group is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/A
Cronos GroupC$146.59M9.24-C$32.78M-C$0.02N/A

Cronos Group has a consensus target price of C$4.38, indicating a potential upside of 21.53%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Aurinia Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurinia Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Aurinia Pharmaceuticals has a net margin of 0.00% compared to Cronos Group's net margin of -6.37%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurinia PharmaceuticalsN/A N/A N/A
Cronos Group -6.37%-0.87%-3.73%

In the previous week, Cronos Group had 1 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 1 mentions for Cronos Group and 0 mentions for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score.

Company Overall Sentiment
Aurinia Pharmaceuticals Neutral
Cronos Group Neutral

4.4% of Cronos Group shares are held by institutional investors. 46.4% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Cronos Group beats Aurinia Pharmaceuticals on 9 of the 13 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRON vs. The Competition

Export
MetricCronos GroupDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$1.35BC$1.63BC$6.25BC$11.72B
Dividend YieldN/A2.97%2.73%6.22%
P/E Ratio-180.004.1829.0423.83
Price / Sales9.241,488.53476.6113.46
Price / Cash1.6710.3727.6282.69
Price / Book1.2110.729.674.48
Net Income-C$32.78MC$21.15BC$3.55BC$300.68M
7 Day Performance-0.55%-1.18%1.70%0.12%
1 Month Performance2.27%0.15%5.62%2.88%
1 Year Performance37.40%24.15%34.42%57.78%

Cronos Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRON
Cronos Group
1.8087 of 5 stars		C$3.60
-0.8%		C$4.38
+21.5%		N/AC$1.35BC$146.59MN/A450
APHA
Aphria
N/AN/AN/AN/AC$5.24BC$611.06MN/A1,200
PBH
Premium Brands
3.434 of 5 stars		C$85.25
+2.2%		C$116.36
+36.5%		N/AC$4.43BC$7.48B94.72540
BHC
Bausch Health Companies
0.5813 of 5 stars		C$7.79
+1.7%		N/AN/AC$2.91BC$10.27B18.5519,900
SLS
Solaris Resources
1.6716 of 5 stars		C$13.91
+3.0%		C$19.50
+40.2%		N/AC$2.32BN/AN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:CRON) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel